molecules of the month


allosteric MALT1 protease (paracaspase) inh.

oral QD act. in xenograft; on-target pathology

from 1M cmpd biochem. HTS and opt.

J. Med. Chem., Nov. 20, 2020

Novartis, Basel, CH

Chemical structure of the MLT-985 (Novartis allosteric MALT1 protease inhibitor)
1 min read

MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: